160 related articles for article (PubMed ID: 37078771)
21. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
Kaye KS; Bhowmick T; Metallidis S; Bleasdale SC; Sagan OS; Stus V; Vazquez J; Zaitsev V; Bidair M; Chorvat E; Dragoescu PO; Fedosiuk E; Horcajada JP; Murta C; Sarychev Y; Stoev V; Morgan E; Fusaro K; Griffith D; Lomovskaya O; Alexander EL; Loutit J; Dudley MN; Giamarellos-Bourboulis EJ
JAMA; 2018 Feb; 319(8):788-799. PubMed ID: 29486041
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial Stewardship Reduces Surgical Site Infection Rate, as well as Number and Severity of Pancreatic Fistulae after Pancreatoduodenectomy.
Cengiz TB; Jarrar A; Power C; Joyce D; Anzlovar N; Morris-Stiff G
Surg Infect (Larchmt); 2020 Apr; 21(3):212-217. PubMed ID: 31697194
[No Abstract] [Full Text] [Related]
23. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
[TBL] [Abstract][Full Text] [Related]
24. The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.
Tanaka K; Nakamura T; Imai S; Kushiya H; Miyasaka D; Nakanishi Y; Asano T; Noji T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
Surg Today; 2018 Sep; 48(9):825-834. PubMed ID: 29687153
[TBL] [Abstract][Full Text] [Related]
25. Extended Versus Narrow-spectrum Antibiotics in the Management of Uncomplicated Appendicitis in Children: A Propensity-matched Comparative Effectiveness Study.
Cameron DB; Melvin P; Graham DA; Glass CC; Serres SK; Kronman MP; Saito JM; Rangel SJ
Ann Surg; 2018 Jul; 268(1):186-192. PubMed ID: 28654543
[TBL] [Abstract][Full Text] [Related]
26. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
Siami FS; LaFleur BJ; Siami GA
Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
[TBL] [Abstract][Full Text] [Related]
27. Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S; Bach F; Brenner T; Bracht H; Brinkmann A; Annecke T; Hohn A; Weigand M; Michels G; Kluge S; Nierhaus A; Jarczak D; König C; Weismann D; Frey O; Witzke D; Müller C; Bauer M; Kiehntopf M; Neugebauer S; Lehmann T; Roberts JA; Pletz MW;
Intensive Care Med; 2022 Mar; 48(3):311-321. PubMed ID: 35106617
[TBL] [Abstract][Full Text] [Related]
28. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction.
Simons JP; Johnson JT; Yu VL; Vickers RM; Gooding WE; Myers EN; Pou AM; Wagner RL; Grandis JR
Laryngoscope; 2001 Feb; 111(2):329-35. PubMed ID: 11210884
[TBL] [Abstract][Full Text] [Related]
29. Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital.
Marra F; Reynolds R; Stiver G; Bryce E; Sleigh K; Frighetto L; MacDougall C; Jewesson P
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):355-68. PubMed ID: 9635910
[TBL] [Abstract][Full Text] [Related]
30. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
Yost RJ; Cappelletty DM;
Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
[TBL] [Abstract][Full Text] [Related]
31. Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy.
Fong ZV; McMillan MT; Marchegiani G; Sahora K; Malleo G; De Pastena M; Loehrer AP; Lee GC; Ferrone CR; Chang DC; Hutter MM; Drebin JA; Bassi C; Lillemoe KD; Vollmer CM; Fernández-Del Castillo C
JAMA Surg; 2016 May; 151(5):432-9. PubMed ID: 26720272
[TBL] [Abstract][Full Text] [Related]
32. Comparing cefazolin/ metronidazole, piperacillin-tazobactam, or c efoxitin as surgical antibiotic prophylaxis in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
Park LJ; D'Souza D; Kazi T; Rodriguez F; Griffiths C; McKechnie T; Mertz D; Serrano PE
J Surg Oncol; 2024 Apr; ():. PubMed ID: 38664921
[TBL] [Abstract][Full Text] [Related]
33. Correlation Between Postoperative Antimicrobial Prophylaxis Use and Surgical Site Infection in Children Undergoing Nonemergent Surgery.
He K; Nayak RB; Allori AC; Brighton BK; Cina RA; Ellison JS; Goretsky MJ; Jatana KR; Proctor MR; Grant C; Thompson VM; Iwaniuk M; Cohen ME; Saito JM; Hall BL; Newland JG; Ko CY; Rangel SJ
JAMA Surg; 2022 Dec; 157(12):1142-1151. PubMed ID: 36260310
[TBL] [Abstract][Full Text] [Related]
34. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
Youssif E; Aseeri M; Khoshhal S
J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
[TBL] [Abstract][Full Text] [Related]
35. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
Zakrison TL; Hille DA; Namias N
Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
[TBL] [Abstract][Full Text] [Related]
36. [Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery].
Ferrer J; Fondevila C; Bombuy E; Fuster J; Alvarez G; Charco R; García-Valdecasas JC
Cir Esp; 2006 Jun; 79(6):365-9. PubMed ID: 16769001
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
[TBL] [Abstract][Full Text] [Related]
38. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
Bow EJ; Rotstein C; Noskin GA; Laverdiere M; Schwarer AP; Segal BH; Seymour JF; Szer J; Sanche S
Clin Infect Dis; 2006 Aug; 43(4):447-59. PubMed ID: 16838234
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.
Fan SY; Shum HP; Cheng WY; Chan YH; Leung SM; Yan WW
Pharmacotherapy; 2017 Jan; 37(1):109-119. PubMed ID: 27888542
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
Dela Pena AS; Asperger W; Köckerling F; Raz R; Kafka R; Warren B; Shivaprakash M; Vrijens F; Giezek H; DiNubile MJ; Chan CY;
J Gastrointest Surg; 2006 Apr; 10(4):567-74. PubMed ID: 16627223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
